China Pharmaceutical Contract Customization Services Exhibition

ICSE China, China’s pharmaceutical contract customization service exhibition, integrates pharmaceutical industry resources from around the world to help Chinese pharmaceutical companies expand rapidly. It is jointly organized by UBM and the China Chamber of Commerce for the Import and Export of Medicines and Health Products. After decades of development, the service line of pharmaceutical contract outsourcing industry has basically covered all stages of new drug research and development, becoming an indispensable link in the industrial chain of research and development. pharmaceutical development. Among them, the emerging CRO and CMO market represented by the Asia-Pacific region is currently in a rapid growth stage, with a growth rate well above the global average.

ICSE China, China’s pharmaceutical contract customization service exhibition, is the first CRO & CMO theme exhibition in the domestic pharmaceutical industry. It brings together high-quality CRO and CMO companies at home and abroad, focusing on introducing advanced products and technologies in the field of pharmaceutical R&D and outsourcing services. Visitors to the exhibition mainly come from Japan, South Korea, North America, Europe, India, Southeast Asia and other countries and regions, including biopharmaceutical companies from world renowned such as Roche, Merck, Amgen, Eli Lilly, Bayer, Johnson & Johnson, Sanofi. , Novartis and AstraZeneca, director of administration and purchasing of the company. On this occasion, many renowned exhibitors will exchange cutting-edge products and technologies in the field of pharmaceutical R&D and production outsourcing services, and discuss many future changes in the industry.

ICSE China, China’s pharmaceutical contract customization service exhibition, has created an information exchange platform for industry insiders that integrates commerce, socialization and knowledge acquisition.

Customization of the contract:Large-scale process production, process development and optimization, synthesis and intermediate production, API synthesis and production, preparation production

R&D under contract:Biotechnology, synthesis customization, medicinal chemistry, clinical research, registration and regulation, other related services